These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30059005)

  • 1. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
    Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
    Elife; 2018 Jul; 7():. PubMed ID: 30059005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combinatorially regulated RNA splicing signature predicts breast cancer EMT states and patient survival.
    Qiu Y; Lyu J; Dunlap M; Harvey SE; Cheng C
    RNA; 2020 Sep; 26(9):1257-1267. PubMed ID: 32467311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
    Harvey SE; Xu Y; Lin X; Gao XD; Qiu Y; Ahn J; Xiao X; Cheng C
    RNA; 2018 Oct; 24(10):1326-1338. PubMed ID: 30042172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.
    Shapiro IM; Cheng AW; Flytzanis NC; Balsamo M; Condeelis JS; Oktay MH; Burge CB; Gertler FB
    PLoS Genet; 2011 Aug; 7(8):e1002218. PubMed ID: 21876675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β.
    Tripathi V; Sixt KM; Gao S; Xu X; Huang J; Weigert R; Zhou M; Zhang YE
    Mol Cell; 2016 Nov; 64(3):549-564. PubMed ID: 27746021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.
    Tanaka I; Chakraborty A; Saulnier O; Benoit-Pilven C; Vacher S; Labiod D; Lam EWF; Bièche I; Delattre O; Pouzoulet F; Auboeuf D; Vagner S; Dutertre M
    Nucleic Acids Res; 2020 Mar; 48(5):2676-2693. PubMed ID: 31943118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing.
    Hu X; Harvey SE; Zheng R; Lyu J; Grzeskowiak CL; Powell E; Piwnica-Worms H; Scott KL; Cheng C
    Nat Commun; 2020 Jan; 11(1):486. PubMed ID: 31980632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.
    Xu Y; Gao XD; Lee JH; Huang H; Tan H; Ahn J; Reinke LM; Peter ME; Feng Y; Gius D; Siziopikou KP; Peng J; Xiao X; Cheng C
    Genes Dev; 2014 Jun; 28(11):1191-203. PubMed ID: 24840202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.
    Göttgens EL; Span PN; Zegers MM
    Int Rev Cell Mol Biol; 2016; 327():163-194. PubMed ID: 27692175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.
    Di Modugno F; Iapicca P; Boudreau A; Mottolese M; Terrenato I; Perracchio L; Carstens RP; Santoni A; Bissell MJ; Nisticò P
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19280-5. PubMed ID: 23129656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state.
    Katz Y; Li F; Lambert NJ; Sokol ES; Tam WL; Cheng AW; Airoldi EM; Lengner CJ; Gupta PB; Yu Z; Jaenisch R; Burge CB
    Elife; 2014 Nov; 3():e03915. PubMed ID: 25380226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
    Ma HR; Cao L; Wang F; Cheng C; Jiang R; Zhou H; Xie Z; Wuermanbieke S; Qian Z
    Oncol Rep; 2020 May; 43(5):1536-1546. PubMed ID: 32323860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking.
    Pillman KA; Phillips CA; Roslan S; Toubia J; Dredge BK; Bert AG; Lumb R; Neumann DP; Li X; Conn SJ; Liu D; Bracken CP; Lawrence DM; Stylianou N; Schreiber AW; Tilley WD; Hollier BG; Khew-Goodall Y; Selth LA; Goodall GJ; Gregory PA
    EMBO J; 2018 Jul; 37(13):. PubMed ID: 29871889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.
    Fici P; Gallerani G; Morel AP; Mercatali L; Ibrahim T; Scarpi E; Amadori D; Puisieux A; Rigaud M; Fabbri F
    Oncotarget; 2017 Jan; 8(2):2423-2436. PubMed ID: 27911856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
    Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quaking isoforms cooperate to promote the mesenchymal phenotype.
    Neumann DP; Phillips CA; Lumb R; Palethorpe HM; Ramani Y; Hollier BG; Selth LA; Bracken CP; Goodall GJ; Gregory PA
    Mol Biol Cell; 2024 Feb; 35(2):ar17. PubMed ID: 38019605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
    Chang JG; Yang DM; Chang WH; Chow LP; Chan WL; Lin HH; Huang HD; Chang YS; Hung CH; Yang WK
    PLoS One; 2011; 6(6):e18643. PubMed ID: 21694768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells.
    Oh J; Pradella D; Shao C; Li H; Choi N; Ha J; Ruggiero S; Fu XD; Zheng X; Ghigna C; Shen H
    Cells; 2021 Apr; 10(4):. PubMed ID: 33918758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.